Intercept Pharmaceuticals Inc Est. EPS Q / Q
¿Qué es el Est. EPS Q / Q de Intercept Pharmaceuticals Inc?
El Est. EPS Q / Q de Intercept Pharmaceuticals Inc es -68.29%
¿Cuál es la definición de Est. EPS Q / Q?
La tasa de crecimiento prospectiva trimestral del EPS, año tras año, es el aumento estimado del EPS de la compañía para el próximo trimestre en comparación con el comportamiento de un trimestre correspondiente anterior.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q de compañías en Sector Health Care en NASDAQ en comparadas con Intercept Pharmaceuticals Inc
¿Qué hace Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Empresas con est. eps q / q similar a Intercept Pharmaceuticals Inc
- Centrais Electricas Brasileiras S.A.- Eletrobras tiene Est. EPS Q / Q de -68.75%
- Journey tiene Est. EPS Q / Q de -68.75%
- Mohawk tiene Est. EPS Q / Q de -68.69%
- Red Rock Resorts Inc tiene Est. EPS Q / Q de -68.67%
- United Fire Inc tiene Est. EPS Q / Q de -68.64%
- NCL Industries tiene Est. EPS Q / Q de -68.40%
- Intercept Pharmaceuticals Inc tiene Est. EPS Q / Q de -68.29%
- Affle (India) tiene Est. EPS Q / Q de -68.20%
- First Quantum Minerals tiene Est. EPS Q / Q de -68.18%
- Lands` End tiene Est. EPS Q / Q de -68.18%
- Osmotica Pharmaceuticals Plc tiene Est. EPS Q / Q de -68.18%
- PQ Inc tiene Est. EPS Q / Q de -68.18%
- ACRES Commercial Realty Corp tiene Est. EPS Q / Q de -68.12%